comparemela.com
Home
Live Updates
Eli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% Premium : comparemela.com
Eli Lilly Acquiring Cancer Therapy Developer For $1.4 Billion—A Nearly 90% Premium
American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion that comes as manu...
Related Keywords
United States ,
American ,
Eli Lilly ,
David Ricks ,
Jacob Van Naarden ,
Novartis ,
Point Biopharma Global ,
Van Naarden ,
Global Oncology Trends ,
Loxo Oncology ,
Iqvia ,
comparemela.com © 2020. All Rights Reserved.